Literature DB >> 22796888

Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.

Jorge Parra-Ruiz1, Alejandra Bravo-Molina, Alejandro Peña-Monje, José Hernández-Quero.   

Abstract

OBJECTIVES: The aim of the study was to assess the in vitro activity of linezolid and daptomycin, alone and in combination, against three Staphylococcus aureus isolates using a pharmacokinetic/pharmacodynamic (PK/PD) model of biofilm for 3 days.
METHODS: One non-clinical methicillin-resistant S. aureus isolate (N315) and two clinical methicillin-resistant S. aureus isolates were evaluated. Simulated regimens included high-dose daptomycin (10 mg/kg once daily) and linezolid (600 mg twice daily), alone and in combination.
RESULTS: Against all three strains, neither linezolid nor daptomycin alone was bactericidal against biofilm-embedded bacteria (BB). Against planktonic bacteria (PB) only daptomycin was bactericidal. In contrast, the combination of linezolid and daptomycin demonstrated greater activity than either of the two agents alone, being bactericidal against both PB and BB, almost reaching the limit of detection at 72 h.
CONCLUSIONS: In this in vitro PK/PD model of mature biofilms, a combination of linezolid plus daptomycin was more effective than each agent alone, representing another potential option to treat S. aureus biofilm-associated infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796888     DOI: 10.1093/jac/dks272

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model.

Authors:  Ashley D Hall Snyder; Brian J Werth; Poochit Nonejuie; John P McRoberts; Joe Pogliano; George Sakoulas; Juwon Yim; Nivedita Singh; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.

Authors:  Wafi Siala; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Marie Hallin; Olivier Denis; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

3.  In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.

Authors:  J Córdoba; N M Coronado-Álvarez; D Parra; J Parra-Ruiz
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

4.  Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.

Authors:  Megan K Luther; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

5.  Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein.

Authors:  Huayong Liu; Dan Zhao; Jun Chang; Liang Yan; Fuju Zhao; Youcong Wu; Tao Xu; Ting Gong; Li Chen; Nianan He; Yang Wu; Shiqing Han; Di Qu
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-17       Impact factor: 4.813

6.  Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.

Authors:  Qun Yan; Melissa J Karau; Yash S Raval; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

7.  New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain.

Authors:  Arianna Pompilio; Serena De Nicola; Valentina Crocetta; Simone Guarnieri; Vincenzo Savini; Edoardo Carretto; Giovanni Di Bonaventura
Journal:  BMC Microbiol       Date:  2015-05-21       Impact factor: 3.605

Review 8.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003

9.  Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus.

Authors:  Yu-Feng Zhou; Wei Shi; Yang Yu; Meng-Ting Tao; Yan Q Xiong; Jian Sun; Ya-Hong Liu
Journal:  Front Microbiol       Date:  2016-01-07       Impact factor: 5.640

10.  Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center.

Authors:  Sandrine Roux; Florent Valour; Judith Karsenty; Marie-Claude Gagnieu; Thomas Perpoint; Sébastien Lustig; Florence Ader; Benoit Martha; Frédéric Laurent; Christian Chidiac; Tristan Ferry
Journal:  BMC Infect Dis       Date:  2016-02-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.